Daily Management Review

Warren Buffett invests in pharmaceutics


02/15/2018


American billionaire investor Warren Buffett invested $ 360 million in the purchase of shares in the Israeli pharmaceutical company Teva, which caused a revival in the stock market. Teva’s shares jumped in price by 11%, raising the quotes of other pharmaceutical companies.



thetaxhaven
thetaxhaven
Last night, Warren Buffett's investment company Berkshire Hathaway notified the American regulators (SEC) that it bought 18.9 million shares of the Israeli pharmaceutical company Teva for $ 358 million, thus adding this pharmaceutical producer to its investment portfolio. In addition, Warren Buffett increased his investments in Apple, buying another 31.2 million shares. It is reported that Berkshire almost completely got rid of IBM shares. Recall that if in the middle of last year it owned 37 million shares of this high-tech company, then by the end of the year the volume fell to 2 million.

Berkshire Hathaway’s notice to the SEC caused a noticeable stir in the business media and among investors. It has long been known that Warren Buffett prefers to buy small stakes in companies without focusing on any one company or sector. The high degree of diversification of the Berkshire Hathaway investment portfolio and the in-depth analysis of the companies' potential is one of the hallmarks of Warren Buffett's strategy, through which he was dubbed the "investment guru". That's why every Buffett investment decision, especially related to adding new companies to the portfolio or removing shares from other companies, causes an instant reaction of the stock market. This time, the news that Warren Buffett added shares of the large pharmaceutical manufacturer to Berkshire's portfolio, led Teva shares to jump in price by 11%. In addition, Buffett's interest in the pharmaceutical company has also provoked optimism among investors in other large companies in this sector - Novartis, AstraZeneca, Takeda, Sanofi and many other large pharmaceutical corporations' quotations increased by 1.2-2.3%.

At the same time Buffett's bid for the pharmaceutical market cannot be called unexpected. In late January, Berkshire Hathaway, along with JP Morgan and Amazon, announced plans to establish a joint company that will carry out research and development in the field of health. It was reported that the activities of this joint company will be aimed not at making profits and doing business, but at reducing the costs of maintaining the health and treatment of employees of the three companies, which employ about 1.1 million people in total. "The rising prices for medicine in the US behave like insatiable worms, biting into our economy," Warren Buffett said at the time. "So far, we cannot offer an explicit answer to this problem. However, we do not want to put up with this as something inevitable. We want to find together a solution that would provide talented people with quality medical services, while keeping the costs of these services under control. "

source: cnn.com
 






Science & Technology

Apple takes up to develop Apple Watch for health monitoring

Hyperloop is growing in Europe

Analysts: US gamers prefer mobile games

Google Assistant Winner Of Head-To-Head Test Of Digital Assistants, Beats Siri And Alexa

Animals Can Burn Muscle To Supplement Body Water Needs, Finds A Study

The future of private flights at Farnborough air show

Experts Want To Fix Problem Of AI Hurting People Of Color And The Poor

New Study Claims Astrobiologists Locating Possible Life On Moon In Its Life Time

Wreck Of Russian Ship Rumoured To Have 5,500 Boxes Of Gold Found Near South Korean Island

Gene Editing of Human Embryo Could Find ‘Moral’ Grounds: UK’s Ethics Council

World Politics

World & Politics

Venezuela comes up with a new monetary reform

Paris is losing its icon public bicycle sharing system

Heat wave in Europe creates problems for brewers

Is it legal to print a gun? US is discussing 3D printing of firearms

Southeast Asian Leaders To Seek Clarity Of US Policies For The Region Form Pompeo

The world economy is accumulating environmental debt

US To Invest $113 Million In Asia To Counter Chinese Influence

US Intelligence Detects New Activity At Its Missile ICBM Factory: Reports